Tizanidine
Product Images NDC 50436-0252

6 FDA label images from Unit Dose Services · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50436-0252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1.jpg (Figure 1)

Figure-1.jpg (Figure 1)
A line chart showing the mean plasma tizanidine concentration (ng/mL) over time (hours from dosing) for tizanidine tablets and capsules (2 x 4 mg) under fasted and fed conditions. The graph compares concentration profiles for both dosage forms with and without food intake over a 24-hour period.*
FDA Label Image

Figure-2.jpg (Figure 2)

Figure-2.jpg (Figure 2)
A line graph titled "Single Dose Study—Mean Change in Muscle Tone from Baseline as Measured by the Ashworth Scale ± 95% Confidence Interval" comparing the effect of 16 mg tizanidine, 8 mg tizanidine, and placebo on muscle tone improvement over 6 hours post-dose. The Y-axis represents improvement in Ashworth Score, where a negative score indicates improvement in muscle tone. Three lines show greater improvement with 16 mg tizanidine, moderate improvement with 8 mg, and minimal change with placebo.*
FDA Label Image

Figure-3.jpg (Figure 3)

Figure-3.jpg (Figure 3)
A chart titled 'Seven Week Study—Mean Change in Muscle Tone 0.5 to 2.5 Hours After Dosing' showing improvement in Ashworth Score with 95% confidence intervals. It compares tizanidine (mean dose 28.8 mg) and placebo groups at three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Negative Ashworth scores indicate improvement in muscle tone.*
FDA Label Image

Label Image (Lbl504360251)

Label Image (Lbl504360251)
tizanidine hydrochloride 2 mg tablet unit dose packaging label by Unit Dose Services. The label shows the active ingredient tizanidine hydrochloride, each tablet containing 2.288 mg equivalent to 2 mg tizanidine. Packaging is for 30 tablets with storage instructions, warnings, and manufacturer details listed as Apotex Inc. Toronto, Ontario, Canada. Includes NDC 50436-0251-1 and Rx Only designation.*
FDA Label Image

Label Image (Lbl504360252)

Label Image (Lbl504360252)
Label for tizanidine hydrochloride 4 mg tablet vial containing 30 tablets from Unit Dose Services. The label displays dosage strength, active ingredient amount per tablet, and manufacturing information by Apotex Inc., Toronto, Ontario, Canada. It includes storage instructions, warnings, and barcode details. The product is Rx only.*
FDA Label Image

Chemical-structure (Tizanidine Imtb 01)

Chemical-structure (Tizanidine Imtb 01)
Chemical structure of tizanidine hydrochloride showing a chlorinated thiazole ring linked to an imidazoline moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.